Amisulpride-induced hyperprolactinaemia is not reversed by addition of aripiprazole

International Journal of Neuropsychopharmacology

Volumn 10, Issue 1, 2007, Pages 149-151

  Paulzen, Michael ^a   Gründer, Gerhard ^a  

^a RWTH AACHEN UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

AMISULPRIDE; ARIPIPRAZOLE; BENPERIDOL; LORAZEPAM; NEUROLEPTIC AGENT; QUETIAPINE;

ADULT; AMENORRHEA; ARTICLE; CASE REPORT; DELUSION; DRUG SUBSTITUTION; DRUG WITHDRAWAL; FEMALE; HALLUCINATION; HUMAN; HYPERPROLACTINEMIA; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PSYCHOSIS; SCHIZOPHRENIA; SIDE EFFECT; SUICIDE ATTEMPT;

ANTIPSYCHOTIC AGENTS; DOPAMINE AGONISTS; DOPAMINE ANTAGONISTS; DRUG THERAPY, COMBINATION; FEMALE; HUMANS; HYPERPROLACTINEMIA; MIDDLE AGED; PIPERAZINES; QUINOLONES; SCHIZOPHRENIA; SULPIRIDE; TREATMENT FAILURE;

EID: 33846316741     PISSN: 14611457     EISSN: 14695111     Source Type: Journal    
DOI: 10.1017/S1461145706007115     Document Type: Article

References (9)

1. David SR, Taylor CC, Kinon BJ (2000). The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia. Clinical Therapeutics 9, 1085-1096.
2. Gründer G, Benkert O (2002). Prolactin secretion is not a core dimension of 'atypicality'. Psychopharmacology (Berlin) 162, 93.
3. Gründer G, Carlsson A, Wong DF (2003). Mechanism of new antipsychotic medications: occupancy is not just antagonism. Archives of General Psychiatry 60, 974-977.
4. Gründer G, Wetzel H, Schlosser R, Anghelescu I, Hillert A, Lange K, Hiemke C, Benkert O (1999). Neuroendocrine response to antipsychotics: effects of drug type and gender. Biological Psychiatry 45, 89-97.
5. Kapur S, Langlois X, Vinken P, Megens AAHP, De Coster R, Andrews JS (2002). The differential effects of atypical antipsychotics on prolactin elevation are explained by their differential blood-brain disposition: a pharmacological analysis in rats. Journal of Pharmacology and Experimental Therapeutics 302, 1129-1134.
6. Keck Jr. PE, Marcus R, Tourkodimitris S, Ali M, Liebeskind A, Saha A, Ingenito G (Aripiprazole Study Group) (2003). A placebo-controlled, double-blind study of the efficacy and safety of aripiprazole in patients with acute bipolar mania. American Journal of Psychiatry 160, 1651-1658.
7. Turrone P, Kapur S, Seeman MV, Flint AJ (2002). Elevation of prolactin levels by atypical antipsychotics. American Journal of Psychiatry 159, 133-135.
8. Wahl R, Ostroff R (2005). Reversal of symptomatic hyperprolactinemia by aripiprazole. American Journal of Psychiatry 162, 1542-1543.
9. 2-like receptors by amisulpride: effects on hormone secretion in healthy volunteers. Journal of Psychiatric Research 28, 461-473.